PROVIDE-HF: Patient Reported Outcomes inVestigation following Initiation of Drug therapy with Entresto (Valsartan/Sacubitril) in Heart Failure.

Administered By

Contributors

Start/End

  • May 12, 2017 - June 30, 2020